Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Japanese
  • Korean
  • Chinese
Cover Image

Radiopharmaceuticals

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic Radiopharmaceuticals, and Therapeutic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

Actinium Pharmaceuticals Inc.
Advanced Medical Isotope Corporation
Alliance Medical
Alseres Pharmaceuticals, Inc.
Avid Radiopharmaceuticals

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

  • Quantitative Techniques & Analytics

Product Definitions And Scope Of Study

  • A. Diagnostic Radiopharmaceuticals
  • B. Therapeutic Radiopharmaceuticals

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Quick Primer
  • Market Drivers
  • Growing Acceptance in Cancer Treatment
  • Increasing Acceptance of Disease-Targeted Treatment
  • Growing Emphasis of Accurate Diagnosis
  • Expanding Molecular Imaging Applications
  • Market Restraints
  • Stringent Regulatory Guidelines
  • Global Supply Shortages
  • Price Sensitivity & Competition from Alternatives
  • Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy
  • Unfounded Fears of Radiation Exposure Hinder Growth
  • Bottlenecks in Developing Markets
  • Recognition of Intrinsic Cost Benefits: Critical to Market Acceptance
  • Market Scenario
  • Recession: A Period of Global Decline
  • The Road to Recovery
  • Impact of Healthcare Budget Cuts in Developed Economies: A Review
  • Current & Future Analysis
  • Diagnostic Radiopharmaceuticals: The Dominant Segment
  • PET: A Prime Growth Driver
  • Introduction of SPECT/CT & PET/CT Boosts Growth
    • Select PET and SPECT Radioisotopes Used in Nuclear Medicine
    • Select Cardiology and Oncology Radiopharmaceuticals
  • New Therapeutic Radiopharmaceuticals to Drive Global Market
  • Rise in Cancer Incidences & Access to Modern Therapeutics Foster Growth
  • World Cancer Statistics - Incidence and Mortality Data
    • Table 1: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 2: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths in Thousands for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 3: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers
  • Competition

2. MARKET TRENDS & ISSUES

  • Companies Explore New Frontiers of Therapeutic Radiopharmaceuticals
  • Targeted Radionuclide Therapy: Gains Ground in Cancer Treatment
  • Battling Alzheimer's Disease - A Powerful Market Force
  • List of FDA Approved Alzheimer's Diagnostic Imaging Agents
  • Hypoxia Imaging Presents Opportunities for PET
  • Rise in Investments and International Collaborations for Drug Development
  • Intra-operative Lymphatic Mapping (ILM): Creates New Opportunities for Radiopharmaceuticals in Cancer Detection
  • Cardiology: An Important Sector for Radiopharmaceuticals
  • PET Application in Drug Development to Expand Opportunities
  • Emergence of Radioisotope Based Personalized Therapy Bodes Well for the Market

3. RADIO ISOTOPES MO-99/TC 99 SUPPLIES - A REVIEW

  • Reactors Producing Cobalt 60 & Molybdenum 99
    • Table 4: Global Projected Demand for Mo-99 in Emerging and Mature Markets for the Years 2020 and 2030 (includes corresponding Graph/Chart)
    • Table 5: Worldwide Market Demand for Mo-99 by Region (2013): Percentage Share Breakdown of Demand for Australia, Canada, China, EU, Japan, Russia, US, and Others (includes corresponding Graph/Chart)
    • Table 6: Worldwide Mo-99 Production by Region (2013): Percentage Share Breakdown of Annual Production for Australia, Canada, EU, Russia, South Africa, and Others (includes corresponding Graph/Chart)
    • Table 7: Global Mo-99 Reactors by Production Capacity (2013): Percentage Share Breakdown of Annual Production Capacity for BR2/Belgium, HFR/ Netherlands, LVR-15/Czech Republic, MARIA/Poland, NRU/Canada, OPAL/Australia, OSIRIS/France, RA-3/Argentina, and SAFARI/South Africa (includes corresponding Graph/Chart)
    • Table 8: Global Tc-99m Processors By Production Capacity (2013): Percentage Share Breakdown Of Annual Production Capacity for AECL/Canada, ANSTO/Australia, CNEA/Argentina, IRE/Belgium, Mallinckrodt/Netherlands, and NTP/South Africa (includes corresponding Graph/Chart)
  • Supply Shortages: A Cause of Concern
  • Combating the Anticipated Shortage of RadioIsotopes
  • Radiopharmacy: A Key Link in the Distribution Chain
    • Table 9: US Radiopharmacies Market (2014): Percentage Share Breakdown of SPECT Doses Sold by Company

4. THERAPEUTIC RADIOPHARMACEUTICAL PRODUCTS UNDER DEVELOPMENT

  • Primer
  • Lutathera for Neuroendocrine Cancer
  • Actimab for Leukemia and Blood Borne Cancers
  • Lead-212 Alpha Therapy for Metastasized Abdominal Cancers
  • Lu-177-J591 PSMA Antibody for Prostate Cancer
  • Indium-111-Pentetreotide for Neuroendocrine Tumors
  • Yttrium-90 Clivatuzumab for Pancreatic Cancer
  • Phospholid Ether Tumor Targeting

5. IMAGING AGENTS - AN OVERVIEW

  • A Quick Primer
  • Growth Drivers
  • Market Restraints
  • Significance of Technological Advancements
  • X-Ray Contrast Media: Giving Way to Emerging Modalities
  • Medical Reimbursement: A Critical Factor
  • Market Structure
  • Select Players by Segment

6. NUCLEAR MEDICINE - AN OVERVIEW

  • Nuclear Medicine - An Introduction
  • Growth Drivers in a Nutshell
  • Market Shifts to Hybrid Imaging

7. PRODUCT OVERVIEW

  • Radiopharmaceuticals: A Definition
  • Mechanism of Action
  • Application of Radiopharmaceuticals
  • Radioactive Tracers for Diagnostic Imaging
  • Therapeutics
  • Research
  • Sterilization
  • Classification of Radiopharmaceuticals
  • Diagnostic Radiopharmaceuticals
    • Commonly Used Diagnostic Radiopharmaceutical Agents
    • Major Isotopes and their Diagnostic Applications
    • Advantages
    • Classification
    • Cardiology Diagnostics
    • Non-cardiology Diagnostics
      • Molecular Imaging Modalities in Radiopharmaceutical Diagnostics
    • Planar Imaging
    • Positron Emission Tomography (PET)
      • Advantages
      • Applications of PET
      • Commonly used Radioisotopes in PET Scans
      • Major PET Isotopes and their Applications
    • Single Photon Emission Computed Tomography (SPECT)
      • Applications of SPECT
      • Commonly used Radioisotopes in SPECT Scans
  • Therapeutic Radiopharmaceuticals
    • Characteristics of Therapeutic Radiopharmaceuticals
    • Commonly used Therapeutic Agents
    • Major Isotopes and their Therapeutic Applications
    • Radiopharmaceuticals for Thyroid Therapy
    • Radiopharmaceuticals for Cancer Therapy
    • Radiopharmaceuticals for Neuroendocrine Tumors
    • Radiopharmaceuticals for Radiosynoviorthesis Therapy
    • Radiopharmaceuticals for Bone Pain Palliation Therapy

8. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Navidea Biopharmaceuticals Launches Lymphoseek
  • Positron Launches Advanced PosiRx Pharmacy Automation Systems
  • BARC Launches Indigenous Radiopharmaceuticals-Powered Scans
  • Rapidscan Pharma Solutions EU and GE Healthcare Unveil Rapiscan(r)

9. RECENT INDUSTRY ACTIVITY

  • Fujifilm Enters the Radiopharmaceutical Market
  • AAA Acquires GE's Italian Radiopharmaceutical Business
  • Triad Isotopes Awarded HealthTrust Contract
  • Positron Enters Licensing Agreement with Russian INR
  • Siemens to Offer PET Pharmaceutical Services in US Market
  • Zevacor Molecular Acquires Pioneer Radiopharmacy
  • Navidea Enters Agreement with Siemens' PETNET Solutions
  • Positron Enters Supply Agreement with iThemba Labs
  • Covidien Spins Off Pharmaceuticals Business
  • Navidea Enters Agreement with Nordion
  • Lantheus Enters into Agreement with Fujifilm
  • Advanced Accelerator Applications Expands Radiopharmaceutical Manufacturing Network
  • Advanced Accelerator Applications Inks Partnership Agreement with Uwrc Spoka Z Ograniczon Odpowiedzialno Ci
  • Eli Lilly to Purchase Two Radiopharmaceutical Imaging Agents from Siemens
  • UPPI Inks Contract with Novation
  • Dalton Inks Manufacturing Partnership with Clarity Pharmaceuticals
  • Lantheus Medical Imaging Extends Agreement with Nordion
  • Lantheus Medical Imaging and Jubilant HollisterStier Enter into Agreement
  • NCM Reveals New Advanced PET Radiopharmaceutical Manufacturing Center
  • Turkey Inaugurates First Particle Accelerator
  • SK Capital and IBA Sign Agreement to Setup IBA Molecular Imaging

10. FOCUS ON SELECT PLAYERS

  • Actinium Pharmaceuticals Inc (US)
  • Advanced Medical Isotope Corporation (US)
  • Alliance Medical (UK)
  • Alseres Pharmaceuticals, Inc (US)
  • Avid Radiopharmaceuticals (US)
  • Bayer HealthCare Medical Care (US)
  • Bracco Diagnostics, Inc. (US)
  • Cardinal Health, Inc (US)
  • GE Healthcare (UK)
  • Ion Beam Applications S.A (Belgium)
  • Immunomedics, Inc. (US)
  • Jubilant Pharma (India)
  • Lantheus Medical Imaging Inc (US)
  • Mallinckrodt Pharmaceuticals (Ireland)
  • Medi-Radiopharma Ltd (Hungary)
  • Nordion, Inc. (Canada)
  • Peregrine Pharmaceuticals, Inc. (US)
  • PETNET Solutions Inc (US)
  • Positron Corporation (US)
  • Singapore Radiopharmaceuticals Pte Ltd (Singapore)
  • Triad Isotopes, Inc. (US)

11. GLOBAL MARKET PERSPECTIVE

    • Table 10: World Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 12: World 15-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current & Future Analysis for Therapeutic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Therapeutic Radiopharmaceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for Therapeutic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Industry Structure
      • Production Scenario
      • Dependence on Imports
    • Regulatory Scenario
      • Thorny Regulations Dampen New Product Development
    • Market Overview
      • Expanding Diagnostic Applications Stimulate Future Growth
      • Cardiovascular Imaging to Lead Volume Growth
    • Table 19: The US Diagnostic Radiopharmaceutical Agents Market (2014): Percentage Share Breakdown of Procedure Volume by Imaging Procedure - SPECT and PET (includes corresponding Graph/Chart)
    • Table 20: US Market for Diagnostic Radiopharmaceuticals Agents (2014): Percentage Share Breakdown of Value Sales for Cardiology and Non-Cardiology Applications (includes corresponding Graph/Chart)
      • New Neurology Agents to Boost Growth
      • List of FDA Approved Alzheimer's Diagnostic Imaging Agents
      • Alzheimer's Stats
    • Table 21: Alzheimer's Prevalence in the US: As a Percentage of Population by Age-Group (includes corresponding Graph/Chart)
    • Table 22: US Market for Non-Cardiology Diagnostic Radiopharmaceuticals Agents (2014): Percentage Share Breakdown of Value Sales for Oncology and Non-Oncology Applications (includes corresponding Graph/Chart)
      • Adoption of SPECT/CT Scanners on Rise
      • Radiopharmaceuticals in PET Imaging - Prospects
      • Focused R&D Efforts to Fuel Therapeutic Radiopharmaceuticals Market
    • Market Share Statistics
    • Table 23: US Market for Diagnostic Radiopharmaceuticals Agents (2014): Percentage Market Share Breakdown for Leading Players (includes corresponding Graph/Chart)
    • Table 24: US Market for Therapeutic Radiopharmaceuticals (2014): Percentage Share Breakdown of Value Sales by Key Radiotherapeutics - Bone Palliation, Non-Hodgkin's Lymphoma, Hyperthyroidism/Thyroid Cancer and Others (includes corresponding Graph/Chart)
    • Table 25: US Market for Therapeutic Radiopharmaceutical Agents (2014E): Percentage Market Share Breakdown of Leading Players (includes corresponding Graph/Chart)
      • Rising Incidence of Cancer - A Major Growth Driver
    • Table 26: US Cancer Incidence (2014): No. of Reported New Cases by Gender (includes corresponding Graph/Chart)
    • Table 27: US Incidence of Common Cancers (2014): Number of New Cases Reported by Affected Site (includes corresponding Graph/Chart)
    • Overview of Medicare Reimbursements
      • Medicare Payment Settings for Radiopharmaceuticals
    • Table 28: Select 2015 Medicare Payment for Hospital Outpatients and Physician Office
      • Contrast Agents and Diagnostic Radiopharmaceuticals Bundled As Supplies
    • Table 29: Packaged components of SPECT Multiple Myocardial Perfusion Procedure
    • Product Launches
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 30: US Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: US Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 32: US 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Canadian Scientists Gear up to find Remedy for Mo-99 Supply Shortages
    • An Overview of Medical Imaging Market
    • Regulatory and Legal Restrictions
    • Select Players
  • B. Market Analytics
    • Table 33: Canadian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Canadian Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 35: Canadian 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Healthcare in Japan
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 36: Japanese Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: Japanese Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 38: Japanese 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Competitive Scenario
    • Key Statistics
    • Table 39: European Radiopharmaceuticals Market (2014): Percentage Share Breakdown of Revenues by Company (includes corresponding Graph/Chart)
    • Table 40: European Diagnostic Radiopharmaceuticals Market (2014): Percentage Share Breakdown of Value Sales by Imaging Modalities - SPECT and PET (includes corresponding Graph/Chart)
    • Market Trends
      • New Applications and Products Augur Good Market Prospects
  • B. Market Analytics
    • Table 41: European Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: European Historic Review for Radiopharmaceuticals by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 43: European 15-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 44: European Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: European Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: European 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 47: French Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: French Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: French 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 50: German Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 51: German Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 52: German 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 53: Italian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Italian Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 55: Italian 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
    • Select Players
  • B. Market Analytics
    • Table 56: UK Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 57: UK Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 58: UK 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 59: Spanish Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 60: Spanish Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 61: Spanish 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 62: Russian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 63: Russian Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 64: Russian 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Market Overview
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 65: Rest of Europe Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 66: Rest of Europe Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 67: Rest of Europe 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 69: Asia-Pacific Historic Review for Radiopharmaceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 70: Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 71: Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 72: Asia-Pacific Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 73: Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Medical Imaging Device Market - An Overview
  • B. Market Analytics
    • Table 74: Chinese Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 75: Chinese Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 76: Chinese 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • Product Launch
    • Jubilant Pharma - A Key Player
  • B. Market Analytics
    • Table 77: Indian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 78: Indian Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 79: Indian 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
    • Singapore Radiopharmaceuticals Pte Ltd. - A Key Player
  • B. Market Analytics
    • Table 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Rest of Asia-Pacific Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 82: Rest of Asia-Pacific 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 83: Middle East Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Middle East Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 85: Middle East 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 86: Latin American Recent Past, Current & Future Analysis for Radiopharmaceuticals by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Latin American Historic Review for Radiopharmaceuticals by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 88: Latin American 15-Year Perspective for Radiopharmaceuticals by Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 89: Latin American Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Latin American Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: Latin American 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7a. BRAZIL

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 92: Brazilian Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Brazilian Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 94: Brazilian 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7b. REST OF LATIN AMERICA

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 95: Rest of Latin America Recent Past, Current & Future Analysis for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 96: Rest of Latin America Historic Review for Radiopharmaceuticals by Segment - Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 97: Rest of Latin America 15-Year Perspective for Radiopharmaceuticals by Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Show More
Pricing
Back to Top